July 2018

Accuracy advises Debiopharm

Accuracy performed the vendor due diligence for Debiopharm Investment in the context of its fundraising activities for Carbonex.

More accuracy news

February 2023

Economic brief – A triple look at 2023

In this edition of the Economic Brief, we focus on what 2023 may have in store from three different perspectives: that of chief economists, that of CEOs and that of the markets. We will see that the views are not necessarily consistent between them, with the macroecono...

Read the article